Mary McNamara-Cullinane
General Counsel bij CLEARPOINT NEURO, INC.
Profiel
Mary McNamara-Cullinane is currently the Vice President-Regulatory Affairs at Clearpoint Neuro, Inc. She previously worked as the Director-Regulatory Affairs & Quality Assurance at Molecular Biometrics, Inc. and as the Vice President-Regulatory & Clinical Affairs at Echo Therapeutics, Inc. Ms. McNamara-Cullinane obtained an undergraduate degree from Massachusetts College of Liberal Arts.
Actieve functies van Mary McNamara-Cullinane
Bedrijven | Functie | Begin |
---|---|---|
CLEARPOINT NEURO, INC. | General Counsel | 08-08-2022 |
Eerdere bekende functies van Mary McNamara-Cullinane
Bedrijven | Functie | Einde |
---|---|---|
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | General Counsel | - |
ECHO THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Mary McNamara-Cullinane
Massachusetts College of Liberal Arts | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
CLEARPOINT NEURO, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Molecular Biometrics, Inc.
Molecular Biometrics, Inc. Miscellaneous Commercial ServicesCommercial Services Molecular Biometrics, Inc. used to develop analytical methodologies for molecular diagnostic. It developed highly specific and sensitive analytical methodologies for molecular diagnostic and monitoring applications in medicine, and for drug discovery and development through pharmacodiagnostics. The company was founded in 2005 and was headquartered in Norwood, MA. | Commercial Services |
Echo Therapeutics, Inc.
Echo Therapeutics, Inc. Medical SpecialtiesHealth Technology Echo Therapeutics, Inc. is a medical device company, which engages in the development of non-invasive, and wireless continuous glucose monitoring system for use in the diabetes outpatient market. It offers needle-free skin preparation device as a platform technology that allows for enhanced skin permeation enabling extraction of analytes, such as glucose and delivery of topical pharmaceuticals. The company was founded in 1989 and is headquartered in Iselin, NJ. | Health Technology |